- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP
- Report
- January 2026
- 185 Pages
Global
From €3982EUR$4,500USD£3,412GBP
- Report
- January 2026
- 185 Pages
Global
From €3982EUR$4,500USD£3,412GBP
- Report
- August 2025
- 180 Pages
Global
From €3982EUR$4,500USD£3,412GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP
- Report
- August 2026
- 368 Pages
Global
From €5176EUR$5,850USD£4,436GBP
- Report
- August 2026
- 171 Pages
Global
From €5176EUR$5,850USD£4,436GBP
- Report
- August 2026
- 371 Pages
Global
From €5176EUR$5,850USD£4,436GBP
- Report
- August 2026
- 293 Pages
Global
From €5176EUR$5,850USD£4,436GBP
- Report
- July 2026
- 110 Pages
Global
From €4203EUR$4,750USD£3,602GBP
- Report
- July 2026
- 118 Pages
Global
From €4203EUR$4,750USD£3,602GBP
- Report
- June 2026
- 147 Pages
Global
From €2654EUR$2,999USD£2,274GBP
€3538EUR$3,999USD£3,032GBP
- Report
- December 2025
- 150 Pages
Global
From €4291EUR$4,850USD£3,677GBP
- Report
- October 2025
- 150 Pages
Global
From €4291EUR$4,850USD£3,677GBP
- Report
- April 2026
- 160 Pages
Global
From €2938EUR$3,320USD£2,517GBP
€3672EUR$4,150USD£3,147GBP

The Cell Therapeutic market is a subset of the biopharmaceutical industry, focusing on the development and commercialization of cell-based therapies. These therapies involve the use of living cells, either from the patient or from a donor, to treat a variety of diseases. Cell therapies can be used to replace or repair damaged cells, to stimulate the body's own immune system to fight disease, or to deliver drugs directly to the site of a disease. Cell therapies are being developed for a wide range of diseases, including cancer, autoimmune diseases, and genetic disorders.
Cell therapies are often complex and expensive to develop, and require specialized manufacturing processes. As a result, the Cell Therapeutic market is highly regulated, with stringent safety and efficacy requirements.
Some companies in the Cell Therapeutic market include Kite Pharma, Juno Therapeutics, and Bluebird Bio. Show Less Read more